My Family’s Autoimmune Disease Journey Is the Tie That Binds

FDA Approves Tavneos as Add-on Therapy for Severe MPA, GPA

The U.S. Food and Drug Administration (FDA) has approved Tavneos (avacopan) as an add-on therapy for people with severe active microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA), the two most common forms of ANCA-associated vasculitis. The approval comes after an advisory committee narrowly supported avacopan’s approval…

I’m Not Afraid of Aging

The year I turned 30, I experienced a vague sense of panic. It seemed like the age at which the fundamental aspects of life — career, family, hobbies — coalesce into permanence. I had recently moved across the country to resettle in a new city that I enjoyed. My work…

‘Rare’ Documentary in Kickstarter Campaign to Raise $45K by Oct. 28

A crowdfunding campaign aims to raise $45,000 to support “Rare,” a documentary film featuring the struggles and achievements of people living with rare diseases and their families. Sweis Entertainment and Digital Cave Media launched the campaign — allowing filmmakers to finish producing and to release the documentary — on Kickstarter.

ChemoCentryx’s Tavneos Approved in Japan for MPA, GPA

The Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved Tavneos (avacopan) for the treatment of microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA). The approval of this first-in-class therapy — for the two main forms of ANCA-associated vasculitis (AAV) — was granted to Kissei Pharmaceuticals, which…

Being Sick Has Taught Me Empathy

It’s an experience every pet owner fears: Our 8-month-old German shepherd needed to be rushed to the emergency vet. Luckily, four hours and several hundred dollars later, he was sent home with some meds and pronounced just fine. While my husband and I were overjoyed that our beloved pup was…

New Data-sharing Program Aims to Speed Innovation in Rare Diseases

A new U.S. initiative called Rare Disease Cures Accelerator–Data and Analytics Platform — dubbed RDCA–DAP — aims to accelerate treatment innovation across rare diseases by sharing existing patient data and promoting the standardization of new data collection. Launched during a virtual workshop in September, the U.S. Food and Drug…

Acknowledging the Changing Seasons of Health

This summer was a lovely one. My days were filled with friendship, travel, gardening, and delicious cuisine. I had enough work to keep busy, but wasn’t overloaded. We even brought home a new puppy — a gorgeous, white German shepherd that is smart and loyal. I had so many good…